March 6 (Reuters) - Independent international pharmaceutical group Servier will buy Day One Biopharmaceuticals DAWN.O for a total equity value of about $2.5 billion, the companies said on Friday.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.